Organic Chemistry TRIZ Cases

Charged agents disrupt disulfide bonds in HER2 and EGFR extracellular domains, inducing apoptosis while minimizing off-target cellular uptake.

Octenyl sulfate ester delivers long-lasting sweetness while inhibiting epithelial sodium channels to reduce saltiness without compromising palatability.

Combining specific host compounds reduces driving voltage while increasing luminous efficiency and extending lifespan in OLED panels.

Composite host materials mitigate the trade-off between luminous efficiency and lifespan in organic electroluminescent devices.

Chemically amplified resist composition incorporating a specific onium salt structure as an acid diffusion inhibitor.

Heterocyclic compounds improve charge carrier mobility and thermal stability to resolve space charge losses in organic light-emitting diodes.

Isosorbide polyurethane copolymers minimize chromatic aberration while maintaining high light transmittance via optimized Abbe values.

Novel sulfonamide derivatives modulate F-2,6-P2 levels to inhibit glucose metabolism in cancer cells.

Substituted five-membered heteroaryl benzamides inhibit TrkA receptors, reducing side effects from broad-spectrum kinase inhibitors.

Tailored photoacid generator composition increases EUV photospeed while reducing line edge roughness and outgassing.

Ionic salt depolymerization recovers intact carbon fibers, avoiding the strength loss caused by thermal pyrolysis.

Thioether compounds self-catalyze epoxy resin curing, eliminating catalyst complexity while maintaining high lap shear strength.

Novel sigma-1 receptor ligands provide neuroprotection and improve cognitive function in patients with Alzheimer's disease.

A plasticizer composition combining di(2-propylheptyl) phthalate and citrate-based materials to enhance tensile strength and elongation in resin systems.

New hydroxylated fatty amides dissolve directly in plasticizers to provide thixotropic control without preactivation.

A bifunctional chimeric compound recruits E3 ubiquitin ligases to degrade androgen receptors.

An organic ammonium salt preserves the steric structure of biological samples in solid and solution states.

Metal-free organic emitters resolve the efficiency-stability trade-off in OLEDs by achieving high photoluminescence quantum yields through TADF mechanisms.

Formula I pyrrolidinyl amides block TLR7 and TLR9 signaling to reduce toxicity while treating systemic lupus erythematosus.

Small molecule inhibitors overcome poor cellular permeability of peptides by optimizing binding affinity and oral bioavailability.

Peripherally restricted cannabinoid receptor modulating compounds reduce food intake and body weight without causing neuropsychiatric side effects.

Pyridine N-oxide compounds inhibit the NLRP3 inflammasome, addressing the lack of specific therapeutics for inflammaging and hearing loss.

Substituted polycyclic carbamoylpyridone derivatives inhibit cap-dependent endonuclease to overcome resistant strains and side effects.

Heterocyclic sGC activators bypass impaired NO signaling by directly stimulating the enzyme despite heme iron oxidation.

Novel styrylpyridine derivatives cross the blood-brain barrier to detect and inhibit amyloid aggregation, addressing poor MRI precision.

Oxiranyl ester additives form stable anode films that minimize irreversible lithium consumption and maintain low internal resistance.

Selective xanthine inhibitors block tryptophan hydroxylases, reducing adverse effects from non-targeted serotonin signaling.

Compounds targeting the FRS2 PTB domain disrupt FGFR signaling, reducing metastatic cell motility and off-target toxicity.

Pyrazolopyrimidine and imidazo[1,5-a]pyrazine inhibitors selectively block parasite kinases, reducing infection while sparing human hosts from nephrotoxicity.

Side-draw extraction removes diol impurities from the extractant circulation loop, preventing hydrolysis and maintaining high product purity.

Small singlet-triplet energy gaps enable reverse intersystem crossing, overcoming low exciton utilization limits in deep blue displays.

Cyclic lactam compounds serve as matrix materials in organic electroluminescent devices to enhance device performance.

Nitrogen-containing heterocyclic compounds serve as matrix materials in organic electroluminescent devices.

Microbial biosynthesis using Aspergillus and Mortierella strains produces pure enantiomers through stereoselective hydroxylation.

Fluorine-substituted precursors eliminate atmospheric doping to produce stable N-type graphene nanoribbons with precise armchair edge structures.

Ethyleneamines extract adsorbed sulfur compounds from saturated beds, enabling onsite regeneration and reducing processing costs.

Cyclophane mediators position fluorophores at fixed distances, boosting neutron-gamma discrimination without compromising polymer stability.

Fused bicyclic triazole derivatives selectively modulate gamma-secretase activity, reducing amyloid-beta 42 levels while preserving Notch signaling pathways.

Synthesizing chromenoisoquinolines that bind dopamine receptors with high selectivity.

Thermally activated delayed fluorescence compounds transfer population between singlet and triplet states.

Amine functionalized ionic absorbent optimizes viscosity and molecular weight to reduce oxidative degradation and continuous makeup requirements.

A nitrogen-heterocyclic compound serves as a capping layer material to increase external quantum efficiency in organic light-emitting devices.

Developing Forms alpha, beta, and gamma resolves solubility and stability limitations in pharmaceutical formulations.

A dual surfactant digester additive composition combines anionic and polyoxyalkylene glycol components to enhance pulp yield during wood chip cooking.

Adding strong acid salts to glycidyl methacrylate compositions prevents quaternary ammonium salt-induced inhibitor deactivation during storage.

Warming the container to 50°C or higher creates an azeotropic vapor mixture that maintains constant n-butylamine concentration during supply.

Modular optimization of isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl structures reduces toxicity while maintaining potent FXR activation.